Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
jRCT2051250028Completed
Randomised, double-blind trial in dry eye syndrome (DED) comparing OC-01 varenicline nasal spray with Placebo nasal spray (2 arms). Primary endpoint: Mean change from baseline in Tear Film Break-up Time (TBUT) at Week 4 (Day 29). Started May 2025; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on jRCT2051250028.